The Chulabhorn Graduate Institute (CGI) and the ASEAN Foundation (AF) have entered into an agreement to develop highly qualified human resources in the area of science and technology within ASEAN Member States through the Chulabhorn Graduate Institute – ASEAN Foundation Post-graduate Scholarship Programme in Science and Technology (Phase 2: 2016 – 2022).

The CGI is a multidisciplinary post-graduate academic institute established in 2005, under the initiative of Professor Dr. Her Royal Highness Princess Chulabhorn Mahidol. The aim of CGI is to employ the most recent interactive teaching techniques used in world leading educational and research institutions to train trainees in the programme to be effective thinkers and leaders in their field of expertise, to better serve their countries’ needs towards sustainable development. The CGI is presently offering programmes leading to Master’s degree in Applied Biological Sciences: Environmental Health, Environmental Toxicology, and Chemical Biology.

The ASEAN Foundation is an organisation from and for the people of ASEAN. Three decades after ASEAN was established, the ASEAN Leaders recognised that there remained inadequate shared prosperity, ASEAN awareness, and contact among the people of ASEAN. It was of this concern that the ASEAN Leaders established the ASEAN Foundation during the ASEAN’s 30th Anniversary Commemorative Summit in Kuala Lumpur, Malaysia, on 15 December 1997. The ASEAN Foundation exists because of one vision: to build a cohesive and prosperous ASEAN Community. As an ASEAN’s body, the ASEAN Foundation is tasked to support ASEAN mainly in promoting awareness, identity, interaction, and development of the people of ASEAN.

This year, eight (8) scholarships are available for ASEAN nationals (except Thai citizen) who are interested to pursue a Master Degree at the CGI. Selection of successful applicants will be based on merit.


Scholarships are open to bonafide ASEAN nationals (except Thai citizen) who meet the following qualifications:

 Under 30 years of age

 Hold a Bachelor Degree with a cumulative GPA of at least 3.00 in one of the following fields:

  • Sciences: Chemistry, Biological, Biological Sciences, Molecular Biology, Environmental Sciences
  • Medical Sciences: Medicine, Medical Technology
  • Pharmacy or Pharmaceutical Sciences

Applicants from other related fields are also welcome to apply.

 Have experience in scientific laboratory research

 Must have demonstrated English proficiency, preferably on one of two recognised tests of language proficiency (TOEFL, IELTS)

 Must provide a statement of purpose explaining their interests in the study

Field of Study

 Applied Biological Sciences: Environmental Health

 Environmental Toxicology

 Chemical Biology

Scholarship Coverage

The scholarship will cover tuition and other academic fees (credit fee, laboratory expenses, refresher course, enrollment fee, thesis fee, production of thesis documents), round trip airfare, visa fee, first settlement allowance, relocation allowance, accommodation, monthly stipend, book allowance, health insurance, among others.

Award Period

The scholarship award will cover six (6) weeks refresher courses and follow by a period of two (2) years Master’s Degree study, subject to an annual review of the scholar’s satisfactory progress.

Note: Refresher courses will tentatively commence in May 2019 while the academic programme will commence in August 2019.

Application Procedure

Applicants should complete the Chulabhorn Graduate Institute – the ASEAN Foundation Post-graduate Scholarship Programme’s application form and submit together with other supporting documents through the following channel:

(1) Send via e-mail the scanned file of the application form and all the supporting document to:

The Chulabhorn Graduate Institute (CGI Scholarship Programme)

54 Kamphangphet 6 Road, Talat Bang Khen, Laksi, Bangkok 10210 THAILAND

This email address is being protected from spambots. You need JavaScript enabled to view it.

(2) After step (1) is completed, send all the original documents via postal services to the address as stated in (1).

Note: No consideration will be given to application with incomplete of supporting documents.

Supporting Document

Following documents must be submitted together with application form:

1) Full Academic Transcript

2) Three Recommendation Letters

3) Statement of Purpose explaining interest of study

4) Medical History Report

5) Other supporting documents to facilitate application screening

Application Period

Applications for the CGI-AF Scholarship Programme is due on 31 November 2018.

Notification of the Award

Successful applicants will be notified of the outcome by the CGI around February 2019.

Application Form

Please find the enclosed CGI-AF scholarship application form and medical history report.

For more information, please contact



The Chulabhorn Graduate Institute

54 Kamphangphet 6 Road, Talat Bang Khen, Laksi, Bangkok 10210 THAILAND


This email address is being protected from spambots. You need JavaScript enabled to view it.



(66 2) 554-1900 ext. 2155, 2130


(66 2) 554-1990, 554-1992



ASEAN Foundation


Jl. Sam Ratulangi No. 2 Menteng, Jakarta 10350, INDONESIA


This email address is being protected from spambots. You need JavaScript enabled to view it.



(62 21) 3192-4828, 3192- 4833


(62 21) 3192-6078

The Asia Pacific Center for Theoretical Physics (APCTP) will open a few positions for APEC Young Scientist Training (YST) Program at the postdoctoral fellow level in Theoretical Physics and related fields. The YST Program was launched by APCTP in 2015 under the APEC Policy Partnership in Science, Technology and Innovation (PPSTI). The Program is for APEC physicists who are at an early age of their research career and provides the opportunity for post-doctoral researchers from APEC member economies to work at the APCTP for a period of up to two (2) years. The APCTP offers APEC YST fellows an ideal environment for research and potential collaborations with in-house senior academics, faculty and visiting scholars from Korea and abroad.

Funding is initially available for one (1) year, renewable for second year depending on the research performance and availability of resources for the program. An annual salary, including severance pay is within the range of KRW 32,500,000 to KRW 40,000,000 depending on the research experience and qualification. In addition to the salary, some research expenses and part of relocation cost, KRW 3,000,000/ year will also be provided. The starting date is expected to be on 01 November 2018.

Suitable applicants are required to submit their application packet consisting of: (1) CV; (2) publication list; (3) short description of applicant’s research accomplishments and future plans; (4) at least (2) recommendation letters from referees directly to This email address is being protected from spambots. You need JavaScript enabled to view it. after receiving notification of endorsement to APCTP as the International Technology Cooperation (ITCU-DOST) will have to evaluate all applications.

Please submit to ITCU-DOST all the required documents for application not later than 03 August 2018 for evaluation and onward endorsement to APCTP.


Department of Science and Technology- Philippine Council for Health Research and Development (DOST- PCHRD)

Philippine applicants are advised to check with the Council regarding the eligibility and requirements. Interested applicants may visit the Department of Science and Technology- Philippine Council for Health Research and Development website for the Grants-in-Aid and Call guidelines (


Research proposals may be submitted by Filipino applicants with the following as Implementing Agencies:
Research and Development Institutions (RDIs)
CHED- accredited Higher Education Institutions (HEIs)
State Colleges and Universities
Private/ non- governmental organizations with proven track record in R&D

The submitted project proposals shall undergo the evaluation process of DOST- PCHRD. Approved projects will be funded by the DOST- PCHRD accordingly and are subject to PCHRD rules and monitoring.

Funding modalities

The DOST – PCHRD shall finance the project expenditures as itemized in the approved line- item budget (LIB) following the DOST Grants-in-Aid guidelines. The grant will cover a maximum of PhP 5,000,000.00 provided that the Implementing Agency will contribute counterpart funding. The grant may cover partial or full cost of the project, both direct and indirect cost of the Maintenance and Other Operating Expenses (MOOE) under the General Appropriations Act (GAA) which shall include Personal Services (PS), Maintenance and Other Operating Expenses (MOOE) and Capital Outlay (CO) that are integral in the conduct of the study. All expenditure items in the LIB shall be in accordance with the Unified Account Code Structures (UACS), relevant provisions are as follows:

  Direct Cost

     Covers the expenses incurred by the implementing institution in executing the project considered indispensable to its operations.

           I.    Personal Services
                Includes salaries, wages, honoraria, fees and other compensation to consultants and specialists who undertake specific activities requiring expertise and technical skills.

           II.   Maintenance and Other Operating Expenses
                   Includes traveling expenses, communication expenses, repair and maintenance of facilities/ vehicles, transportation and delivery services, supplies and materials, utilities, training and scholarship expenses, representation expenses, professional expenses, and expenses on advertising, printing and binding, subscription and survey.
           III. Capital Outlay
This includes all equipment necessary for the implementation of the project, which shall be enumerated in the proposed LIB. Equipment shall still be subject to the evaluation of DOST PCIEERD, this also includes infrastructure that are integral part of the project and are crucial in the attainment of the project’s objective

     Indirect Cost

        Cost used to cover the overhead expenses by the implementing institution in managing and monitoring the project. The administrative and project management cost shall fall under this account. Similar to Direct Cost, the Indirect Cost can be broken down according to specific item under PS and MOOE. The total indirect cost of the project shall not exceed 7.5% of the total PS and MOOE of the project.


Prior to the submission of a full blown proposal, applicants are requested to submit a capsule proposal through the email addresses indicated below. Two (2) hard copies should be mailed to the Department of Science and Technology- Philippine Council for Health Research and Development (DOST- PCHRD), 1st floor, Saliksik Building, General Santos Avenue,  Bicutan, Taguig City 1631. All proposals are also required to be registered in the Project Management System (PMS: The capsule proposal should not exceed five (5) pages and should include the workplan and line- item budget. Institutions with shortlisted capsule proposals will then be requested to submit a full blown proposal.

For more information, please contact:

Mary Ann I. Pacho
Science Research Specialist II
This email address is being protected from spambots. You need JavaScript enabled to view it. / 837 7535 loc 304

Christine May D. Gaylan
Science Research Specialist I
This email address is being protected from spambots. You need JavaScript enabled to view it. / 837 2017 loc 2111

Download File


The Department of Health (DOH), through its AHEAD (Advancing Health through Evidence-Assisted Decisions) strategy, aims to inform the health sector’s global and national administrative and legislative policy agenda, create an equitable and enabling environment for health policy and systems researchers all over the country, and ensure the progressive realization of the envisioned research system.

With the continued commitment of DOH in training the next generation for health sector leaders, researchers, policy analysts, and program managers, they have partnered with the Department of Science and Technology - Philippine Council for Health Research Development (DOST-PCHRD) in order to implement the DOH Research Fellowship Program.

The program is a two-year intensive Health Policy and Systems Research Fellowship intended for early career professionals who are considering a career in research. A pre-fellowship or internship is being made available for highly qualified applicants who demonstrate interest in health policy and systems research in the context of research to policy translation. Graduates of the internship program may proceed to apply to the fellowship program.


To develop capacity of Health Policy and Systems Research Interns in the process of research to policy translation


  1. Standard deliverables
    • Accomplishment report approved by the DOH supervisor every month
    • Back-to-Office report for all meetings/workshops attended
    • Technical report for all meetings/workshops organized
    • One brown bag session organized or facilitated every month
    • At least 5 memoranda every month
  2. Station-dependent, in addition to #1:
    • At least 2 policy reviews every month; includes drafting policy issuances as maybe needed, if deployed to Health Policy Division
    • At least 2 program strategy, and performance/plan analysis and budget analysis every month, if deployed to Health Planning Division
    • At least 2 position papers every month, if deployed to the Legislative Liaison Division


  1. Adhere to agency policies, procedures, and rules governing professional behaviour
  2. Be punctual, and work the required number of hours: 8am to 5pm Monday to Friday
  3. Notify their supervisor if they are unable to attend
  4. Behave and dress appropriately to the particular workplace
  5. Respect the confidentiality of the workplace, its clients and its employees.
  6. If things are slow, take the initiative and volunteer for different tasks or other work.
  7. Discuss any problems with their supervisor and, if necessary, with the Internship coordinator at the Health Policy Development and Planning Bureau
  8. Other technical tasks as may be required

Minimum Qualifications:

  1. Bachelor’s degree, field of study must be on public health or any related area in the social and medical sciences; post-graduate degree is an advantage
  2. At least one (1) year work experience, previous work experience in DOH is a plus factor
  3. At least eight (8) hours of relevant training


  1. A genuine interest in health policy issues 
  2. Excellent English-language writing skills and the ability to present information in a variety of formats and styles for difference audiences
  3. Strong skills in planning, preparing and delivering remarks
  4. Strong organizational and administrative skills; with keen attention to detail
  5. Strong interpersonal skills and the ability to work well in a team with others
  6. Ability to develop work plans, set deadlines, work well with minimal supervision, prioritize assignments, and organize multiple projects and duties simultaneously while meeting deadlines
  7. Ability to work effectively as a member of a team, know when to act independently and when to consult for advice on decision-making
  8. A willingness to carry out a wide range of activities, including both professional and logistical tasks
  9. Strong computer skills with familiarity with Microsoft Office, email clients, Internet research, and social networking tools
  10. Flexibility with respect to schedule, working hours, travel, and work assignments, including ability to work overtime or on weekends when necessary; reliable job attendance essential


Two years, non-renewable


For BS/BA degree holders: At least PHP 25,000.00 NETT

            For MS/MA degree holders: At least PHP 30,000.00 NETT

Expression of Interest:

Qualified applicants may file their application together with the following documents at This email address is being protected from spambots. You need JavaScript enabled to view it. or This email address is being protected from spambots. You need JavaScript enabled to view it.:

  1. Cover letter addressed to:


Director IV

Health Policy Development and Planning Bureau

Department of Health

  1. Curriculum Vitae

Deadline of submission is on or before July 14, 2018.

For queries, contact Ms. Juanita R. Valeza at 651-7800 local 1326/1328 or Ms. Ian Hannah C. Gozun at (02) 837-7537 local 2117.


Twelve notable outcomes from projects supported by the Philippine Council for Health Research and Development (PCHRD) were featured at AghamBayan Technology and Innovations Festival on 20 June 2018 at the Philippine International Convention Center (PICC), Pasay City.

In one of the parallel sessions, products of PCHRD and University of the Philippines Manila (UPM) research collaboration were presented. Proponents were given the chance to explain and showcase their developed technologies and products to the industry sector.  Among the featured outputs were Newborn Screening, Newborn Hearing Screening, Sambong Tablet, Lab in a Mug, Hemoxyther, Cardio Pharmacogenomics, Lagundi, LeptoVax, Ornathex, RxBox, Rare Diseases Act, and Sin Tax Law.

Dr. Carmencita Padilla, UPM Chancellor, explained that newborn screening has been considered as one of the most successful public health intervention programs in the Philippines with the enactment of Republic Act 9288 or the Newborn Screening Act of 2004. In 1996, Dr. Padilla led a group to research on newborn screening which results were used as basis in the creation of the law. The Newborn screening aims to early detect genetic, metabolic, infectious conditions in newborn babies in order to provide the necessary timely interventions. To date, more than 10 million babies and was able to save 120 000 babies from mental retardation or death.

Other laudable policies presented were the Republic Act No. 9709 or the Universal Newborn Hearing Screening and Intervention Act of 2009, Republic Act No. 10747 or the Rare Disease Act and the Republic Act No. 10351 or Sin Tax Law. The Universal Newborn Hearing Screening and Intervention Act provides for mandatory hearing tests for all Filipino newborns, the Rare Disease Act that guarantees improved access of patients diagnosed with rare diseases to comprehensive medical care, and the Sin Tax Law helps reduce smoking prevalence in the country and augment government funds for healthcare financing and delivery.

Herbal medicines developed by Dr. Nelia P. Cortes-Maramba from the Institute of Herbal Medicine were also featured. Sambong Tablet, an herbal medicine produced from Sambong leaf, is used to treat edema and urinary tract infections or stone. The cost of the tablet is 50 percent less compared with the use of medical and surgical alternatives. Lagundi capsule, on the other hand, can treat cough and asthma.

In addition, herbal medicines called Hemoxyther and Ornathex were introduced. According to developer of Hemoxyther, Dr. Erna Arollado of the Institute of Pharmaceutical Sciences, the supplement is used to treat anemia without the usual side effects of commercially available iron supplements. Ornathex, on the other hand, is an anti-pain and anti-inflammatory herbal medicine derived from a plant indigenous in the Philippines called Calamus ornatus locally known as rattan.

The team of Dr. Nina G. Gloriani from the Department of Medical Microbiology presented their innovation called LeptoVax, a leptospirosis vaccine. The vaccine targets the disease-causing bacteria that are appropriate to the Philippine setting, with potential application to neighboring Southeast Asian countries.

An affordable rapid test kit for accurate detection of dengue within an hour, the Biotek-M Dengue Aqua Kit was also showcased.  Part of the “Lab-in-a-Mug Project,” Dr. Raul Destura of the National Institutes of Health declared that the invention won a gold medal at the 46th International Exhibition of Inventions in Geneva, Switzerland.

Another featured innovation is the technology developed by Dr. Portia Fernandez-Marcelo of the National Telehealth Center and Dr. Luis Sison from the Electrical and Engineering Deparment of UP Diliman called RxBox. The RxBox is a telemedicine device capable of capturing medical signals through built-in medical sensors, storing data in an electronic medical record, and transmitting health information via internet to a clinical specialist in the Philippine General Hospital for expert advice.

Also highlighted was the Pharmacogenetics, a research program headed by Dr. Rody Sy and Dr. Eva Cutiongco – de la Paz which focused on the study of inherited genetic differences in drug metabolic pathways that affect individual responses to drugs. The UP-PGH Cardiovascular Genetics Research Group screen known biomarkers related to cardiovascular diseases and response to treatment in the country.

Encouraging more scientist and researchers to innovate on health, PCHRD Executive Director Dr. Jaime Montoya said, “We need your help in producing more research and creating more innovation for our country.”